Guntekin Unal, Gunes Yilmaz, Tuncer Mustafa, Simsek Hakki, Gumrukcuoglu Hasan Ali, Arslan Sevket, Gunes Ahmet
Yuzuncu Yil University, Faculty of Medicine, Cardiology Department, Van, Turkey.
Pacing Clin Electrophysiol. 2009 Apr;32(4):494-9. doi: 10.1111/j.1540-8159.2009.02310.x.
Several studies have reported that hyperthyroidism is associated with prolonged QT interval corrected by the heart rate (QTc) and pulmonary hypertension (PHT).
Forty-seven patients with newly diagnosed overt hyperthyroidism and 20 healthy people were enrolled in the study. Transthoracic echocardiography, 12-lead surface electrocardiogram, and thyroid hormone levels were studied at the time of enrollment and after achievement of euthyroid state with propylthiouracil treatment.
Baseline clinical characteristics were similar. However, heart rate (90.5+/-19.6 vs 79.2+/-13.7 bpm, P = 0.024), pulmonary artery systolic pressure (PASP) (26.0+/-12.0 vs 10.6+/-4.0 mmHg, P < 0.001), E deceleration time (DT) (191.8+/-25.6 vs 177.0+/-10.7 ms, P = 0.016), isovolumetric relaxation time (IVRT) (91.38+/-12.3 vs 79.6+/-10.5 ms, P < 0.001), and QTc dispersion (QTcD) (50.3+/-17.2 vs 38.9+/-11.6 ms, P = 0.009) were significantly higher in hyperthyroid patients compared to control group. Heart rate (to 74.1+/-13.8, P < 0.001), QTcD (to 37.3+/-10.1 ms, P < 0.001), DT (to 185.3+/-19.7 ms, P = 0.008), IVRT (to 88.6+/-10.3 ms, P = 0.056), and PASP (23.1+/-10.1 mmHg P < 0.001) were significantly decreased after achievement of euthyroid state. Although PHT was present in 16 patients before treatment only six patients still had PHT during euyhyroid state. Compared to patients with normal PASP, QTcD was significantly longer in patients with PHT (56.5+/-15.8 vs 37.9+/-12.8 mmHg P < 0.001). There were also significant correlations between QTcD and presence of PHT (r = 0.516, P < 0.001) and PASP (r = 0.401, P = 0.009).
Hyperthyroidism is a reversible cause of PHT and diastolic dysfunction. Increased QTcD observed in hyperthyroidism may be associated with PHT and diastolic dysfunction. These abnormal findings in hyperthyroidism often normalize with the achievement of euthyroid state.
多项研究报告称,甲状腺功能亢进与经心率校正的QT间期延长(QTc)及肺动脉高压(PHT)有关。
本研究纳入了47例新诊断的显性甲状腺功能亢进患者和20名健康人。在入组时以及使用丙硫氧嘧啶治疗达到甲状腺功能正常状态后,对患者进行经胸超声心动图、12导联体表心电图及甲状腺激素水平检测。
基线临床特征相似。然而,甲状腺功能亢进患者的心率(90.5±19.6对79.2±13.7次/分钟,P = 0.024)、肺动脉收缩压(PASP)(26.0±12.0对10.6±4.0 mmHg,P < 0.001)、E波减速时间(DT)(191.8±25.6对177.0±10.7毫秒,P = 0.016)、等容舒张时间(IVRT)(91.38±12.3对79.6±10.5毫秒,P < 0.001)以及QTc离散度(QTcD)(50.3±17.2对38.9±11.6毫秒,P = 0.009)均显著高于对照组。达到甲状腺功能正常状态后,心率(降至74.1±13.8,P < 0.001)、QTcD(降至37.3±10.1毫秒,P < 0.001)、DT(降至185.3±19.7毫秒,P = 0.008)、IVRT(降至88.6±10.3毫秒,P = 0.056)以及PASP(降至23.1±10.1 mmHg,P < 0.001)均显著降低。尽管治疗前16例患者存在PHT,但甲状腺功能正常状态时仅有6例患者仍有PHT。与PASP正常的患者相比,PHT患者的QTcD显著更长(56.5±15.8对37.9±12.8 mmHg,P < 0.001)。QTcD与PHT的存在(r = 0.516,P < 0.001)及PASP(r = 0.401,P = 0.009)之间也存在显著相关性。
甲状腺功能亢进是PHT和舒张功能障碍的可逆性病因。甲状腺功能亢进时观察到的QTcD增加可能与PHT和舒张功能障碍有关。甲状腺功能亢进的这些异常表现通常在达到甲状腺功能正常状态时恢复正常。